Bim is an independent prognostic marker in intrahepatic cholangiocarcinoma.

MLA

Zhang, Henan, et al. “Bim Is an Independent Prognostic Marker in Intrahepatic Cholangiocarcinoma.” Human Pathology, vol. 78, Aug. 2018, pp. 97–105. EBSCOhost, https://doi.org/10.1016/j.humpath.2018.04.009.

APA

Zhang, H., Jenkins, S. M., Lee, C.-T., Harrington, S. M., Liu, Z., Dong, H., & Zhang, L. (2018). Bim is an independent prognostic marker in intrahepatic cholangiocarcinoma. Human Pathology, 78, 97–105. https://doi.org/10.1016/j.humpath.2018.04.009

Chicago

Zhang, Henan, Sarah M Jenkins, Chuang-Ta Lee, Susan M Harrington, Zhuogang Liu, Haidong Dong, and Lizhi Zhang. 2018. “Bim Is an Independent Prognostic Marker in Intrahepatic Cholangiocarcinoma.” Human Pathology 78 (August): 97–105. doi:10.1016/j.humpath.2018.04.009.